Variant report
Variant | nsv521944 |
---|---|
Chromosome Location | chr8:111709802-111713158 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:2)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:2 , 50 per page) page:
1
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs1494240 | chr8:111709802-111709803 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs569998899 | chr8:111709836-111709837 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs193299315 | chr8:111709843-111709844 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs555645001 | chr8:111709882-111709883 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs1494241 | chr8:111709909-111709910 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
6 | rs561848768 | chr8:111709920-111709921 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs375306676 | chr8:111709921-111709922 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs11397465 | chr8:111709936-111709937 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs185460716 | chr8:111709977-111709978 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs557569931 | chr8:111710011-111710012 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs145113245 | chr8:111710024-111710025 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs147569534 | chr8:111710081-111710082 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs200964641 | chr8:111710091-111710092 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs141956354 | chr8:111710092-111710093 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs574023909 | chr8:111710097-111710098 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs542913459 | chr8:111710131-111710132 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs116078652 | chr8:111710149-111710150 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs528690153 | chr8:111710158-111710159 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs545538648 | chr8:111710189-111710190 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs149862573 | chr8:111710199-111710200 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs117270956 | chr8:111710200-111710201 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs551019521 | chr8:111710209-111710210 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs561260932 | chr8:111710218-111710219 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs145844348 | chr8:111710227-111710228 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs549307446 | chr8:111710433-111710434 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs565918221 | chr8:111710525-111710526 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs534538496 | chr8:111710526-111710527 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs377181268 | chr8:111710528-111710529 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs571290007 | chr8:111710537-111710538 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs148981957 | chr8:111710538-111710539 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs113509646 | chr8:111710556-111710557 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs556587139 | chr8:111710595-111710596 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs535890866 | chr8:111710596-111710597 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs535807694 | chr8:111710626-111710627 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs369959562 | chr8:111710783-111710784 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs553396010 | chr8:111710811-111710812 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs555484780 | chr8:111710813-111710814 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs189582727 | chr8:111710820-111710821 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs575847491 | chr8:111710844-111710845 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs566310377 | chr8:111710893-111710894 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs545304939 | chr8:111710902-111710903 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs533674481 | chr8:111710946-111710947 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs565453914 | chr8:111710964-111710965 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs575852429 | chr8:111710997-111710998 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs557090920 | chr8:111711015-111711016 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs180730904 | chr8:111711169-111711170 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs143748597 | chr8:111711194-111711195 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs118134080 | chr8:111711195-111711196 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs530120471 | chr8:111711196-111711197 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs10112109 | chr8:111711197-111711198 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
Disease | PMID | Source |
---|---|---|
Melanoma | 18172304 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Autism | 19415332 | CNVD |
Malaria | 21533027 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Gastric cancer | 17908304 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Breast cancer | 21245420 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Liver carcinoma | 19366792 | CNVD |
Seminomas | 18059402 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Pancreatic cancer | 21811587 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Breast cancer | 17603634 | CNVD |
Testicular cancer | 18059402 | CNVD |
Breast cancer | 17133270 | CNVD |
Breast cancer | 21509527 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Breast cancer | 21858162 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Acute lymphoblastic leukemia | 21248843 | CNVD |
Cancer | 20164919 | CNVD |
abnormal development | 18461090 | CNVD |
Oral cancer | 21386901 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Langer-Giedion syndrome | 22283845 | CNVD |
Cancer | 21637783 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 20632083 | CNVD |
Breast cancer | 19602461 | CNVD |
Cancer | 22429812 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Oral cancer | 19627613 | CNVD |
Prostate cancer | 21088497 | CNVD |
colon cancer | 17210682 | CNVD |
Breast cancer | 21264507 | CNVD |
Breast cancer | 22028636 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Cancer | 16751803 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Gastric cancer | 17167181 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Breast cancer | 16461572 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Medulloblastoma | 16968546 | CNVD |
head and neck squamous cell carcinoma | 18028549 | CNVD |
Breast cancer | 17001317 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 16608533 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Prostate cancer | 18632612 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Prostate cancer | 16573809 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Adenocarcinoma | 21044232 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Prostate cancer | 16461572 | CNVD |
Breast cancer | 21399628 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Breast cancer | 17393978 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
Breast cancer | 17899364 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Autosomal-dominant progressive external ophthalmoplegia | 19664747 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
Sezary syndrome | 18413736 | CNVD |
Breast cancer | 21611746 | CNVD |
Developmental delay | 21147756 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Congenital diaphragmatic hernia | 21525063 | CNVD |
Non-small cell lung cancer | 19010865 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Chronic myeloid leukemia | 21384125 | CNVD |
Barrett''s adenocarcinoma | 18663352 | CNVD |
Breast cancer | 21364760 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr8:111709000-111711000 | Enhancers | Foreskin Keratinocyte Primary Cells skin03 | Skin |
2 | chr8:111709400-111710200 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
3 | chr8:111709400-111710400 | Enhancers | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
4 | chr8:111709400-111710400 | Enhancers | HMEC | breast |
5 | chr8:111709400-111710400 | Enhancers | NHEK | skin |
6 | chr8:111709400-111711400 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
7 | chr8:111709600-111710200 | Enhancers | NH-A | brain |
8 | chr8:111709600-111710400 | Enhancers | Muscle Satellite Cultured Cells | -- |
9 | chr8:111709600-111710400 | Enhancers | Foreskin Keratinocyte Primary Cells skin02 | Skin |
10 | chr8:111709800-111710000 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
11 | chr8:111709800-111710000 | Enhancers | Primary hematopoietic stem cells short term culture | blood |
12 | chr8:111710400-111711200 | Weak transcription | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
13 | chr8:111711200-111711400 | Enhancers | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |